IRIS Accounts Production v25.4.0.155 13335380 Board of Directors 1.5.24 30.4.25 30.4.25 false true false false true false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 13335380 2024-04-30 13335380 2025-04-30 13335380 2024-05-01 2025-04-30 13335380 2023-04-30 13335380 2023-05-01 2024-04-30 13335380 2024-04-30 13335380 ns15:EnglandWales 2024-05-01 2025-04-30 13335380 ns14:PoundSterling 2024-05-01 2025-04-30 13335380 ns10:Director1 2024-05-01 2025-04-30 13335380 ns10:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 13335380 ns10:SmallEntities 2024-05-01 2025-04-30 13335380 ns10:AuditExempt-NoAccountantsReport 2024-05-01 2025-04-30 13335380 ns10:SmallCompaniesRegimeForDirectorsReport 2024-05-01 2025-04-30 13335380 ns10:SmallCompaniesRegimeForAccounts 2024-05-01 2025-04-30 13335380 ns10:FullAccounts 2024-05-01 2025-04-30 13335380 ns10:Director2 2024-05-01 2025-04-30 13335380 ns10:Director3 2024-05-01 2025-04-30 13335380 ns10:RegisteredOffice 2024-05-01 2025-04-30 13335380 ns5:CurrentFinancialInstruments 2025-04-30 13335380 ns5:CurrentFinancialInstruments 2024-04-30 13335380 ns5:Non-currentFinancialInstruments 2025-04-30 13335380 ns5:Non-currentFinancialInstruments 2024-04-30 13335380 ns5:ShareCapital 2025-04-30 13335380 ns5:ShareCapital 2024-04-30 13335380 ns5:RetainedEarningsAccumulatedLosses 2025-04-30 13335380 ns5:RetainedEarningsAccumulatedLosses 2024-04-30 13335380 ns5:LandBuildings 2024-04-30 13335380 ns5:PlantMachinery 2024-04-30 13335380 ns5:LandBuildings 2024-05-01 2025-04-30 13335380 ns5:PlantMachinery 2024-05-01 2025-04-30 13335380 ns5:LandBuildings 2025-04-30 13335380 ns5:PlantMachinery 2025-04-30 13335380 ns5:LandBuildings 2024-04-30 13335380 ns5:PlantMachinery 2024-04-30 13335380 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-04-30 13335380 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-04-30 13335380 ns5:FinanceLeases ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-04-30 13335380 ns5:FinanceLeases ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-04-30 13335380 ns5:FinanceLeases ns5:BetweenOneFiveYears 2025-04-30 13335380 ns5:FinanceLeases ns5:BetweenOneFiveYears 2024-04-30 13335380 ns5:FinanceLeases 2025-04-30 13335380 ns5:FinanceLeases 2024-04-30 13335380 ns5:WithinOneYear 2025-04-30 13335380 ns5:WithinOneYear 2024-04-30 13335380 ns5:BetweenOneFiveYears 2025-04-30 13335380 ns5:BetweenOneFiveYears 2024-04-30 13335380 ns5:AllPeriods 2025-04-30 13335380 ns5:AllPeriods 2024-04-30

REGISTERED NUMBER: 13335380 (England and Wales)

| UNAUDITED FINANCIAL STATEMENTS |

| FOR THE YEAR ENDED 30 APRIL 2025 |

| FOR |

| ADNOVA CLINIC LIMITED |

ADNOVA CLINIC LIMITED (REGISTERED NUMBER: 13335380)

CONTENTS OF THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 APRIL 2025

Page |

Company Information | 1 |

Balance Sheet | 2 |

Notes to the Financial Statements | 4 |

ADNOVA CLINIC LIMITED

COMPANY INFORMATION

FOR THE YEAR ENDED 30 APRIL 2025

| DIRECTORS: | C Durrant

| P S J Heppell

| A Durrant

| REGISTERED OFFICE: | Rex Buildings

| Alderley Road

| Wilmslow

| Cheshire

| SK9 1HY

| REGISTERED NUMBER: | 13335380 (England and Wales)

| ACCOUNTANTS: | Sandison Easson & Co

| Rex Buildings

| Alderley Road

| Wilmslow

| Cheshire

| SK9 1HY

ADNOVA CLINIC LIMITED (REGISTERED NUMBER: 13335380)

BALANCE SHEET

30 APRIL 2025

| 2025 | 2024 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Tangible assets | 4 | 482,935 |  | 637,727 |  |

CURRENT ASSETS

Debtors | 5 | 111,482 |  | 91,082 |  |

Cash at bank | 98,820 |  | 124,824 |  |

210,302 |  | 215,906 |  |

CREDITORS

Amounts falling due within one year | 6 | 1,789,583 |  | 1,787,154 |  |

NET CURRENT LIABILITIES | (1,579,281 | ) | (1,571,248 | ) |

TOTAL ASSETS LESS CURRENT LIABILITIES | (1,096,346 | ) | (933,521 | ) |

CREDITORS

Amounts falling due after more than one year | 7 | (29,942 | ) | (63,866 | ) |

PROVISIONS FOR LIABILITIES | (50,288 | ) | (78,332 | ) |

NET LIABILITIES | (1,176,576 | ) | (1,075,719 | ) |

ADNOVA CLINIC LIMITED (REGISTERED NUMBER: 13335380)

BALANCE SHEET - continued

30 APRIL 2025

| 2025 | 2024 |

| Notes | £ | £ | £ | £ |

CAPITAL AND RESERVES

Called up share capital | 500 |  | 500 |  |

Retained earnings | (1,177,076 | ) | (1,076,219 | ) |

(1,176,576 | ) | (1,075,719 | ) |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 1 December 2025 and were signed on its behalf by:

C Durrant - Director

ADNOVA CLINIC LIMITED (REGISTERED NUMBER: 13335380)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 APRIL 2025

1. | STATUTORY INFORMATION

| Adnova Clinic Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | ACCOUNTING POLICIES

| BASIS OF PREPARING THE FINANCIAL STATEMENTS

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| RELATED PARTY EXEMPTION

| The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

| TURNOVER

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| TANGIBLE FIXED ASSETS

| Depreciation is provided at the following annual rates in order to write off the cost less estimated residual

| value of each asset over its estimated useful life.

| Long Leasehold |  | - |  | 10% on cost |  |

| Improvement to property |  | - |  | 10% on cost |  |

| Plant and machinery |  | - |  | 20% on cost |  |

| Fixture and Fittings |  | - |  | 25% on cost |  |

| Computer Equipment |  | - |  | 25% on cost |  |

ADNOVA CLINIC LIMITED (REGISTERED NUMBER: 13335380)

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 30 APRIL 2025

2. | ACCOUNTING POLICIES - continued

| TAXATION

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| DEFERRED TAX

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| HIRE PURCHASE AND LEASING COMMITMENTS

| Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 18 (2024 - 31 ) .

ADNOVA CLINIC LIMITED (REGISTERED NUMBER: 13335380)

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 30 APRIL 2025

4. | TANGIBLE FIXED ASSETS

| Plant and |

| Land and |  | machinery |

| buildings |  | etc |  | Totals

£ | £ | £ |

| COST

| At 1 May 2024 | 239,846 |  | 849,401 |  | 1,089,247 |  |

| Additions | - |  | 25,068 |  | 25,068 |  |

| At 30 April 2025 | 239,846 |  | 874,469 |  | 1,114,315 |  |

| DEPRECIATION

| At 1 May 2024 | 47,969 |  | 403,551 |  | 451,520 |  |

| Charge for year | 23,984 |  | 155,876 |  | 179,860 |  |

| At 30 April 2025 | 71,953 |  | 559,427 |  | 631,380 |  |

| NET BOOK VALUE

| At 30 April 2025 | 167,893 |  | 315,042 |  | 482,935 |  |

| At 30 April 2024 | 191,877 |  | 445,850 |  | 637,727 |  |

5. | DEBTORS

2025 | 2024 |

£ | £ |

| Amounts falling due within one year:

| Trade debtors | 12,114 |  | 3,134 |  |

| Other debtors | 6,300 |  | 809 |  |

| Prepayments and accrued income | 40,105 |  | 34,176 |  |

58,519 |  | 38,119 |  |

| Amounts falling due after more than one year:

| Rent deposit | 52,963 |  | 52,963 |  |

| Aggregate amounts | 111,482 |  | 91,082 |  |

ADNOVA CLINIC LIMITED (REGISTERED NUMBER: 13335380)

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 30 APRIL 2025

6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Finance leases (see note 8) | 33,924 |  | 32,523 |  |

| Trade creditors | 124,570 |  | 156,493 |  |

| Amounts owed to associates | 1,070,000 |  | 1,070,000 |  |

| PAYE and national insurance | 18,255 |  | 7,410 |  |

| Other creditors | 226,510 |  | 191,553 |  |

| Directors' current accounts | 300,058 |  | 300,058 |  |

| Accrued expenses | 16,266 |  | 29,117 |  |

1,789,583 |  | 1,787,154 |  |

7. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |

2025 | 2024 |

£ | £ |

| Finance leases (see note 8) | 29,942 |  | 63,866 |  |

8. | LEASING AGREEMENTS

| Minimum lease payments fall due as follows:

| Finance leases |

2025 | 2024 |

£ | £ |

| Net obligations repayable:

| Within one year | 33,924 |  | 32,523 |  |

| Between one and five years | 29,942 |  | 63,866 |  |

63,866 |  | 96,389 |  |

| Non-cancellable |

| operating leases |

2025 | 2024 |

£ | £ |

| Within one year | 59,674 |  | 54,170 |  |

| Between one and five years | 84,314 |  | 59,786 |  |

143,988 |  | 113,956 |  |